Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Altius Peripheral Nerve Stimulation in Amputees After TMR/RPNI

NCT: NCT07571239 · NOT_YET_RECRUITING

NCT IDNCT07571239
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2028-07-01

Brief Summary

This is a single-center, prospective, within-subject study. This study seeks to enroll a total of 32 prospective subjects who will undergo surgical implantation of the FDA-approved Altius® system. Subjects will be followed longitudinally and will complete a series of patient-reported outcome measure questionnaires, a study intake questionnaire which assesses demographics, amputation and prosthesis history, and medical/medication history.

Frequently Asked Questions

What is Altius Peripheral Nerve Stimulation in Amputees After TMR/RPNI?

Altius Peripheral Nerve Stimulation in Amputees After TMR/RPNI is a clinical trial registered under NCT07571239. Current status: NOT_YET_RECRUITING.

What is the status of NCT07571239?

The current status of NCT07571239 (Altius Peripheral Nerve Stimulation in Amputees After TMR/RPNI) is: NOT_YET_RECRUITING.

When did Altius Peripheral Nerve Stimulation in Amputees After TMR/RPNI start?

Altius Peripheral Nerve Stimulation in Amputees After TMR/RPNI started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.